Lv11
66 积分 2024-12-25 加入
Aumolertinib as adjuvant therapy in resected EGFR-mutated non-small-cell lung cancer (ARTS): a double-blind, multicentre, randomised, controlled, phase 3 trial
18分钟前
已完结
Ensartinib in Resected ALK-Positive Non-Small-Cell Lung Cancer
59分钟前
已完结
Smartphone application-based pulmonary rehabilitation in COPD: a multicentre randomised controlled trial
5个月前
已完结
Longitudinal effects of ivacaftor and medicine possession ratio in people with the Gly551Asp mutation: a 5-year study
5个月前
已关闭
Pulmonary rehabilitation and quality of life in alpha-1 antitrypsin deficiency: findings from a retrospective cohort study
6个月前
已关闭
Bronchial carcinoma and long-term survival. Retrospective study of 433 patients who underwent resection
6个月前
已完结
Treatment adherence and clinical outcomes of osimertinib in minority patients with advanced EGFR mutated NSCLC
6个月前
已完结
Timing of Curative Surgery in Postoperative Enterocutaneous Fistulas
7个月前
已完结
LKB1 dictates sensitivity to immunotherapy through Skp2-mediated ubiquitination of PD-L1 protein in non-small cell lung cancer
8个月前
已完结
MDM2 drives resistance to Osimertinib by contextually disrupting FBW7-mediated destruction of MCL-1 protein in EGFR mutant NSCLC
8个月前
已完结
皖公网安备34019202002308
